We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Extends COVID-19 Monoclonal Antibody EUA Policy Beyond Pandemic
FDA Guidance Extends COVID-19 Monoclonal Antibody EUA Policy Beyond Pandemic
In a final guidance issued this week, the FDA outlines recommendations for continued development of monoclonal antibody products targeting SARS-CoV-2 to meet emergency needs.